RedX Pharma plc (REDX) Ordinary Shares 1p
Share news, reports & tips
19 August 2019 09:43
(Sharecast News) - Drug discovery and development company Redx Pharma has successfully completed dosing of the first cohort of patients in its ongoing phase 1 and 2 study with 'RXC004', it...
10 June 2019 08:29
(Sharecast News) - Drug discovery and development company Redx Pharma published its interim results on Monday, revealing it had narrowed first-half losses as it progresses on cancer and idiopathic pulmonary...
3 May 2019 11:17
(Sharecast News) - Drug discovery and development company Redx Pharma updated the market on its ongoing plans to strengthen its balance sheet on Friday, with its board reiterating its commitment to...
12 February 2019 13:42
(Sharecast News) - Drug discovery and development company Redx Pharma announced promising preclinical efficacy data for its lead selective 'ROCK2' compound on Tuesday.
31 January 2019 09:45
(Sharecast News) - Drug discovery and development company Redx Pharma announced on Thursday that Deinove had decided not to exercise its option for Redx's 'Novel Bacterial Topoisomerase...
30 November 2018 10:31
(Sharecast News) - Redx Pharma made gains on Friday after it said that pre-clinical data suggested that its RXC006 drug candidate has "great potential" as a treatment for fibrosis.
19 November 2018 08:59
(Sharecast News) - A year after clambering out of administration, drug discovery and development outfit Redx Pharma swung to a loss but remains confident of making progress with a drug pipeline refocused on...
14 November 2018 11:09
(Sharecast News) - Drug discovery and development company Redx Pharma announced the nomination of its first development compound to treat fibrosis on Wednesday.
29 October 2018 14:50
(Sharecast News) - Drug development company Redx Pharma noted an announcement from the UK BioIndustry Association (BIA) on Monday that Lisa Anson had been elected to serve on the BIA board of directors.
30 May 2018 12:59
(Sharecast News) - Drug discovery and development Redx Pharma will restart early-stage clinical trials on its RXC004 product after a phase I/IIa assessment of the cancer drug was temporarily halted in March...
24 April 2018 08:27
(WebFG News) - AIM-quoted drug discovery and development firm Redx has found its new chief executive officer in former AstraZeneca UK president Lisa Anson, marking a "new beginning" as the company...
22 March 2018 11:35
(ShareCast News) - Drug discovery and development company Redx Pharma has signed an option and licence agreement with French high-value compound developer Deinove for its anti-infective programme aimed at...
Company announcements Announcements
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see http://www.DigitalLook.com/newsfeedterms for our terms and conditions.
© Digital Look Ltd 1998-2019. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.